Report cover image

Middle East & Africa Small Molecule Drug Discovery Market Size and Forecast (2021 - 2031)

Publisher The Insight Partners
Published Jan 14, 2026
SKU # TIP20949654

Description

The Middle East & Africa (MEA) small molecule drug discovery market is projected to grow significantly, reaching approximately US$ 1,215.7 million by 2031, up from US$ 632.4 million in 2023, reflecting a compound annual growth rate (CAGR) of 8.6% during the forecast period.

Executive Summary and Market Analysis

The MEA small molecule drug discovery market is categorized into several regions, including the UAE, Saudi Arabia, South Africa, and the Rest of MEA. This market is witnessing consistent growth driven by several factors. The rising incidence of cancer and other chronic diseases has created a robust demand for innovative therapeutic solutions, leading to increased focus on small molecule drug development. Additionally, heightened investments in the healthcare and pharmaceutical sectors from both government and private entities are fostering innovation and improving research infrastructure across the region. Collaborative efforts with organizations and research institutions from developed countries are also accelerating technological advancements and knowledge transfer. The UAE and Saudi Arabia are spearheading initiatives to enhance drug discovery infrastructure, while South Africa is emerging as a key hub for clinical research. Collectively, these developments are expected to propel the MEA small molecule drug discovery market forward in the coming years.

Strategic Insights

Market Segmentation Analysis
  • By Therapeutic Area: The market is segmented into Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas. Oncology dominated the market share in 2023.
  • By Process or Phase: The market is divided into Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development, with Lead Generation and Refinement holding the largest market share in 2023.
Market Outlook

The integration of artificial intelligence (AI) and related technologies is making drug discovery more cost-effective and efficient. AI facilitates innovative data collection and management methods, reducing reliance on manual processes. Leading biopharmaceutical companies are increasingly adopting AI platforms to expedite drug discovery. For example, Pfizer utilizes IBM Watson to enhance its search for immuno-oncology drugs. The rapid adoption of AI in healthcare is prompting numerous pharmaceutical companies to form partnerships with AI firms to identify drug targets and design new medications. Notable collaborations include Merck's partnership with BenevolentAI and Exscientia in 2023, aimed at leveraging AI-driven design capabilities, and Evommune Inc.'s collaboration with Accutar Biotechnology Inc. to discover novel small molecule drug candidates for chronic inflammatory diseases.

Country Insights

The market is further segmented by country, with Saudi Arabia, the UAE, South Africa, and the Rest of MEA. Saudi Arabia held the largest market share in 2023. As the largest economy in the Middle East, Saudi Arabia is committed to enhancing healthcare services, with public and private sectors investing in research initiatives. The Saudi Vision 2031 program aims to diversify the economy and reduce reliance on oil, leading to advancements in healthcare supported by cutting-edge technologies. The rising incidence of cancer in Saudi Arabia, with new cases projected to increase from 27,885 in 2020 to 60,429 by 2040, underscores the urgent need for innovative treatments. The growth of small molecule drug discovery is being driven by the increasing prevalence of chronic diseases and advancements in the pharmaceutical sector.

Company Profiles

Key players in the MEA small molecule drug discovery market include GSK Plc, Charles River Laboratories International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., Merck KGaA, ICON Plc, Revvity Inc., Danaher Corp, Thermo Fisher Scientific Inc., and Oncodesign Services. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. Middle East and Africa Small Molecule Drug Discovery Market - Key Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. Small Molecule Drug Discovery Market - Middle East and Africa Market Analysis
5.1 Middle East and Africa Small Molecule Drug Discovery Market Revenue (US$ Million), 2023 - 2031
5.2 Middle East and Africa Small Molecule Drug Discovery Market Forecast and Analysis
6. Middle East and Africa Small Molecule Drug Discovery Market Revenue Analysis - by Therapeutic Area
6.1 Oncology
6.1.1 Overview
6.1.2 Oncology: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Central Nervous System
6.2.1 Overview
6.2.2 Central Nervous System: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Cardiovascular
6.3.1 Overview
6.3.2 Cardiovascular: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.4 Respiratory
6.4.1 Overview
6.4.2 Respiratory: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.5 Orthopedics
6.5.1 Overview
6.5.2 Orthopedics: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.6 Immunology
6.6.1 Overview
6.6.2 Immunology: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.7 Rare Diseases
6.6.1 Overview
6.6.2 Rare Diseases: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.8 Other Therapeutic Areas
6.8.1 Overview
6.8.2 Other Therapeutic Areas: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. Middle East and Africa Small Molecule Drug Discovery Market Revenue Analysis - by Process Or Phase
7.1 Target Discovery
7.1.1 Overview
7.1.2 Target Discovery: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Target Validation
7.2.1 Overview
7.2.2 Target Validation: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Lead Generation and Refinement
7.3.1 Overview
7.3.2 Lead Generation and Refinement: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Preclinical Development
7.4.1 Overview
7.4.2 Preclinical Development: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. Middle East and Africa Small Molecule Drug Discovery Market - Country Analysis
8.1 Middle East and Africa
8.1.1 Middle East and Africa Small Molecule Drug Discovery Market Revenue and Forecast and Analysis - by Country
8.1.1.1 Middle East and Africa Small Molecule Drug Discovery Market Revenue and Forecast and Analysis - by Country
8.1.2.2 Saudi Arabia: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.1.2.2.1 Saudi Arabia: Middle East and Africa Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.1.2.2.2 Saudi Arabia: Middle East and Africa Small Molecule Drug Discovery Market Share - by Process Or Phase
8.2.3.3 United Arab Emirates: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2.3.3.1 United Arab Emirates: Middle East and Africa Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.2.3.3.2 United Arab Emirates: Middle East and Africa Small Molecule Drug Discovery Market Share - by Process Or Phase
8.3.4.4 South Africa: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3.4.4.1 South Africa: Middle East and Africa Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.3.4.4.2 South Africa: Middle East and Africa Small Molecule Drug Discovery Market Share - by Process Or Phase
8.4.5.5 Rest of Middle East and Africa: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4.5.5.1 Rest of Middle East and Africa: Middle East and Africa Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.4.5.5.2 Rest of Middle East and Africa: Middle East and Africa Small Molecule Drug Discovery Market Share - by Process Or Phase
9 Industry Landscape
9.1 Overview
12 COMPANY PROFILES
10.1 GSK Plc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Charles River Laboratories International Inc
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Boehringer Ingelheim International GmbH
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Bristol-Myers Squibb Co
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Merck KGaA
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 ICON Plc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Revvity Inc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Danaher Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Thermo Fisher Scientific Inc.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Oncodesign Services
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
LIST OF TABLES
Table 1. Middle East and Africa Small Molecule Drug Discovery Market Segmentation
Table 3. Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 5. Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 6. Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 7. Saudi Arabia: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 8. Saudi Arabia: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 9. United Arab Emirates: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 10. United Arab Emirates: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 11. South Africa: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 12. South Africa: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 13. Rest of Middle East and Africa: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 14. Rest of Middle East and Africa: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 15. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Middle East and Africa Small Molecule Drug Discovery Market Segmentation - Country
Figure 4. Middle East and Africa Small Molecule Drug Discovery Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East and Africa Small Molecule Drug Discovery Market Revenue (US$ Million), 2023 - 2031
Figure 7. Middle East and Africa Small Molecule Drug Discovery Market Share (%) - by Therapeutic Area, 2023 and 2031
Figure 8. Oncology: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Central Nervous System: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardiovascular: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Respiratory: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Orthopedics: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Immunology: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Rare Diseases: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Other Therapeutic Areas: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Middle East and Africa Small Molecule Drug Discovery Market Share (%) - by Process Or Phase, 2023 and 2031
Figure 17. Target Discovery: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Target Validation: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Lead Generation and Refinement: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Preclinical Development: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Middle East and Africa Small Molecule Drug Discovery Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 22. Saudi Arabia: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. United Arab Emirates: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. South Africa: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Rest of Middle East and Africa: Middle East and Africa Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Company Positioning & Concentration

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us